Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Norepinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiodermatitis 3 Head and Neck Neoplasms 3 Hypotension 2 Stroke 1 Shock, Septic 1 Optimal Tissue Perfusion 1 Neoplasms 1 Mouth Neoplasms 1 Leiomyoma 1 Alopecia 1

Interventions

Cisplatin 25 Magnetic Resonance Spectroscopy 19 Radiotherapy 16 pembrolizumab 15 Specimen Handling 15 Cetuximab 15 Radiotherapy, Intensity-Modulated 12 Biopsy 11 Carboplatin 10 Radiation 9 Paclitaxel 9 Fluorouracil 9 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Surveys and Questionnaires 7 Surgical Procedures, Operative 7 Drug Therapy 7 X-Rays 6 Standard of Care 6 Celecoxib 6 Taxes 5 Sentinel Lymph Node Biopsy 5 Observation 5 Nivolumab 5 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Chemoradiotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡